Private Equity Other Private Equity/Strategic Investments
Medical devices maker Transasia BioMedicals explores 20% stake sale to raise $200 -M
Source Mint (opens in a new tab)
Mumbai-based medical equipment maker Transasia Bio-Medicals is exploring a sale of a 20% stake to raise USD 150-200 million, drawing interest from private equity funds including TPG, Warburg Pincus, ChrysCapital, Motilal Oswal and Quadria Capital. The round is likely a mix of primary and secondary share sale. O3 Capital is helping the company with the fundraise.Founded in 1979 by Suresh Vazirani, Transasia is among India’s largest in-vitro diagnostics companies, offering solutions across biochemistry, haematology, coagulation, ESR, immunology, urinalysis, critical care, diabetes management, microbiology and molecular diagnostics.
Company website ↗ (opens in a new tab)
For FY25, Transasia Bio-Medicals had reported about INR 1,060 Cr in Operating Income and about INR 234 Cr in PAT.